Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS

Proteomics - Clinical Applications

Volumn 5, Issue 5-6, 2011, Pages 300-310

  Chen, Guixiang ^a   Zhang, Yang ^a   Jin, Xiaohong ^a   Zhang, Lihong ^a   Zhou, Yunjiao ^a   Niu, Jianying ^a   Chen, Jing ^b   Gu, Yong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Preeclampsia; Proteinuria; Renal; Urinary

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIOINFORMATICS; BLOOD CLOTTING; CELL ADHESION; CELL DIFFERENTIATION; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOSKELETON; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DOWN REGULATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; KIDNEY INJURY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN URINE LEVEL; PROTEOMICS; REPRODUCIBILITY; SCREENING TEST; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS;

ACUTE KIDNEY INJURY; ADULT; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; TANDEM MASS SPECTROMETRY;

EID: 79957751483     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000100     Document Type: Article

References (46)

1. Working Group on High Blood Pressure in Pregnancy. (1991) Working Group Report on High Blood Pressure in Pregnancy. National High Blood Pressure Education Program (NHPEP). US Dept Health Human Service pp. 91-3029: pp. 1-46.
2. Parikh, S. M., Karumanchi, S. A., Putting pressure on pre-eclampsia. Nat. Med. 2008, 14, 810-812.
3. Buhimschi, I. A., Zhao, G., Funai, E. F., Harris, N. et al., Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am. J. Obstet. Gynecol. 2008, 199, 551, e551-e516.
4. Sibai, B., Dekker, G., Kupferminc, M., Pre-eclampsia. Lancet 2005, 365, 785-799.
5. Irani, R. A., Xia, Y., The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 2008, 29, 763-771.
6. Thongboonkerd, V., Biomarker discovery in glomerular diseases using urinary proteomics. Proteomics Clin. Appl. 2008, 2, 1413-1421.
7. Sun, W., Chen, Y., Li, F., Zhang, L. et al., Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers. Proteomics Clin. Appl. 2009, 3, 370-382.
8. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D. et al., Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24, 333-338.
9. Han, C. L., Chien, C. W., Chen, W. C., Chen, Y. R. et al., A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease. Mol. Cell. Proteomics 2008, 7, 1983-1997.
10. Zieske, L. R., A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J. Exp. Bot. 2006, 57, 1501-1508.
11. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
12. Akkina, S. K., Zhang, Y., Nelsestuen, G. L., Oetting, W. S., Ibrahlm, H. N., Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition? J. Proteome Res. 2009, 8, 94-103.
13. Keshamouni, V. G., Jagtap, P., Michailidis, G., Strahler, J. R. et al., Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J. Proteome Res. 2009, 8, 35-47.
14. Serrano, J., Higgins, L., Witthuhn, B. A., Anderson, L. B. et al., In vivo assessment and potential diagnosis of xenobiotics that perturb the thyroid pathway: Proteomic analysis of Xenopus laevis brain tissue following exposure to model T4 inhibitors. Comp. Biochem. Physiol. D Genomics Proteomics 2010, 5, 138-150.
15. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J Obstet. Gynecol. 2000, 183, S1-S22.
16. Hansen, H. G., Overgaard, J., Lajer, M., Hubalek, F. et al., Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis. Proteomics Clin. Appl. 2010, 4, 1-9.
17. Saetun, P., Semangoen, T., Thongboonkerd, V., Characterizations of urinary sediments precipitated after freezing and their effects on urinary protein and chemical analyses. Am. J. Physiol. Renal. Physiol. 2009, 296, F1346-F1354.
18. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
19. Auer, J. et al., Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J. Proteomics 2010, 73, 1004-1017.
20. Stillman, I. E., Karumanchi, S. A., The glomerular injury of preeclampsia. J. Am. Soc. Nephrol. 2007, 18, 2281-2284.
21. Karumanchi, S. A., Lindheimer, M. D., Preeclampsia and the kidney: footprints in the urine. Am. J. Obstet. Gynecol. 2007, 196, 287-288.
22. Henao, D. E., Mathieson, P. W., Saleem, M. A., Bueno, J. C., Cadavid, A., A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol. Dial. Transplant 2007, 22, 1477.
23. Vikse, B. E., Irgens, L. M., Bostad, L., Iversen, B. M., Adverse perinatal outcome and later kidney biopsy in the mother. J. Am. Soc. Nephrol. 2006, 17, 837-845.
24. Vikse, B. E., Irgens, L. M., Leivestad, T., Skjaerven, R., Iversen, B. M., Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 2008, 359, 800-809.
25. Thongboonkerd, V., Current status of renal and urinary proteomics: ready for routine clinical application? Nephrol. Dial. Transplant. 2010, 25, 11-16.
26. Thongboonkerd, V., Urinary proteomics: towards biomarker discovery, diagnostics and prognostics. Mol. Biosyst. 2008, 4, 810-815.
27. Caubet, C., Lacroix, C., Decramer, S., Drube, J. et al., Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr. Nephrol. 2010, 25, 27-35.
28. Quintana, L. F., Campistol, J. M., Alcolea, M. P., Banon-Maneus, E. et al., Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol. Cell. Proteomics 2009, 8, 1658-1673.
29. Magistroni, R., Ligabue, G., Lupo, V., Furci, L. et al., Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Nephrol. Dial. Transplant. 2009, 24, 1672-1681.
30. Thongboonkerd, V., Recent progress in urinary proteomics. Proteomics Clin. Appl. 2007, 1, 780-791.
31. Fliser, D., Novak, J., Thongboonkerd, V., Argiles, A. et al., Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 2007, 18, 1057-1071.
32. Görg, A., Drews, O., Luck, C., Weiland, F., Weiss, W., 2-DE with IPGs. Electrophoresis 2009, 30, S122-S132.
33. Ye, H., Sun, L., Huang, X., Zhang, P., Zhao, X., A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS. Mol. Cell. Biochem. 2010, 343, 91-99.
34. Thongboonkerd, V., Practical points in urinary proteomics. J. Proteome Res. 2007, 6, 3881-3890.
35. Macey, M. G., Bevan, S., Alam, S., Verghese, L. et al., Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb. Res. 2010, 125, e76-81.
36. Lewis, D. F., Canzoneri, B. J., Gu, Y., Zhao, S., Wang, Y., Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. Am. J. Reprod. Immunol. 2010, 64, 376-383.
37. Ahn, H., Park, J., Gilman-Sachs, A., Kwak-Kim, J., Immunologic characteristics of preeclampsia, a comprehensive review. Am. J. Reprod. Immunol. 2011, 65, 377-394.
38. Sharp, A. N., Heazell, A. E., Crocker, I. P., Mor, G., Placental apoptosis in health and disease. Am. J. Reprod. Immunol. 2010, 64, 159-164.
39. Gupta, S., Aziz, N., Sekhon, L., Agarwal, R. et al., Lipid peroxidation and antioxidant status in preeclampsia: a systematic review. Obstet. Gynecol. Surv. 2009, 64, 750-759.
40. Engstrom, G., Janzon, L., Berglund, G., Lind, P. et al., Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 2054-2058.
41. Engstrom, G., Lind, P., Hedblad, B., Stavenow, L. et al., Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002, 33, 2744-2749.
42. Schmaier, A. H., The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. J. Clin. Invest. 2002, 109, 1007-1009.
43. Anton, L., Brosnihan, K. B., Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies. Ther. Adv. Cardiovasc. Dis. 2008, 2, 349-362.
44. Urushihara, M., Kondo, S., Kagami, S., Kobori, H., Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am. J. Nephrol. 2010, 31, 318-325.
45. Kobori, H., Alper, A. B. Jr., Shenava, R., Katsurada, A. et al., Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 2009, 53, 344-350.
46. Kobori, H., Ohashi, N., Katsurada, A., Miyata, K. et al., Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J. Am. Soc. Hypertens. 2008, 2, 349-354.